MEF2C and acute lymphoblastic leukemia: Finally, we investigated whether FLT3 inhibitor (PKC412) in combination with ABT737 treatment restore PSL sensitivity more prominently in T-ALL cells with high expression of MEF2C. First, we determined FLT3 expression was much higher in LOUCY than in Jurkat by q-PCR analysis (Fig 5a).